Arcus Biosciences Inc (RCUS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Terry J. Rosen Ph.D.
Employees:
108
3928 POINT EDEN WAY, HAYWARD, CA 94545
650-489-9000

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer therapies in the United States.

Data derived from most recent annual or quarterly report
Market Cap 1.816 Billion Shares Outstanding71.062 Million Avg 30-day Volume 1.002 Million
P/E Ratio39.4121 Dividend Yield0.0 EPS
Price to Revenue5.7825 Debt to Equity0.0 EBITDA70.679 Million
Price to Book Value2.8414 Operating Margin15.2813 Enterprise Value921.068 Million
Current Ratio7.84 EPS Growth0 Quick Ratio7.543
1 Yr BETA 1.6983 52-week High/Low 49.1 / 16.74 Profit Margin14.672
Operating Cash Flow Growth509.6675 Altman Z-Score2.7469 Free Cash Flow to Firm 382.685 Million
View SEC Filings from RCUS instead.

View recent insider trading info

Arcus Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding RCUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RCUS BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-06-21 by Tang Carolyn C.
  • 4: filed on 2022-06-21 by ROSEN TERRY J
  • 4: filed on 2022-06-21 by JARRETT JENNIFER
  • 4: filed on 2022-06-21 by JAEN JUAN C.
  • 4: filed on 2022-06-16 by RIBAS ANTONI
  • 4: filed on 2022-06-16 by PERLMAN ANDREW J
  • 4: filed on 2022-06-16 by MACHADO PATRICK
  • 4: filed on 2022-06-16 by LAMBERT NICOLE
  • 4: filed on 2022-06-16 by LACEY DAVID L.
  • 4: filed on 2022-06-16 by KANEKO YASUNORI

    • Events (8k)

  • 8-K: filed on 2022-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-21:
    Item 8.01: Other Events
  • 8-K: filed on 2021-11-18:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2021-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-07-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-07:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-04-26:
    Item 7.01: Regulation FD Disclosure

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    29.3 Thousand total shares from 12 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ROSEN TERRY J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 3,893,915 2022-06-16 3

    JAEN JUAN C. PRESIDENT

    • Officer
    • Director
    		 1,644,851 2022-06-16 4

    JARRETT JENNIFER CHIEF OPERATING OFFICER

    • Officer
    • Director
    		 118,619 2022-06-16 6

    TANG CAROLYN C. GENERAL COUNSEL

    • Officer
    		 23,909 2022-06-16 3

    PERLMAN ANDREW J

    • Director
    		 27,925 2022-06-14 1

    FALBERG KATHRYN E

    • Director
    		 209,510 2022-06-14 1

    KANEKO YASUNORI

    • Director
    		 920,555 2022-06-14 1

    MACHADO PATRICK

    • Director
    		 26,900 2022-06-14 1

    LACEY DAVID L.

    • Director
    		 59,252 2022-06-14 1

    LAMBERT NICOLE

    • Director
    		 20,900 2022-06-14 3

    RIBAS ANTONI

    • Director
    		 40,503 2022-06-14 1

    GOELTZ II ROBERT C. CHIEF FINANCIAL OFFICER

    • Officer
    		 85,019 2022-03-08 2

    HIGGINS LINDA SLANEC

    • Director
    		 0 2021-08-10 1

    GROSSMAN WILLIAM CHIEF MEDICAL OFFICER

    • Officer
    		 20,723 2021-06-16 0

    GILEAD SCIENCES INC

    • 10% Owner
    		 13,913,029 2021-01-31 0

    QUIGLEY MICHAEL

    • Director
    		 0 2021-01-06 0

    PARSEY MERDAD

    • Director
    		 0 2020-07-13 0

    BARKER JASON SEE REMARKS

    • Officer
    		 10,000 2020-06-04 0

    BEIER DAVID W

    • Director
    		 0 2019-06-06 0

    HEGE KRISTEN

    • Director
    		 0 2019-06-06 0

    HEMRAJANI REKHA SEE REMARKS

    • Officer
    		 0 2019-03-25 0

    CHAN STEVEN SEE REMARKS

    • Officer
    		 0 2019-01-16 0

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    PONOI MANAGEMENT, LLC

    PONOI CAPITAL, LP

    GOEDDEL DAVID V

    SVENNILSON PETER

    KUTZKEY TIM

    • 10% Owner
    		 No longer subject to file 2018-03-19 0

    GV 2016 GP, L.L.C.

    GV 2016 GP, L.P.

    GV 2016, L.P.

    ALPHABET INC.

    • 10% Owner
    		 3,125,312 2018-03-19 0

    GV 2017 GP, L.L.C.

    GV 2017 GP, L.P.

    GV 2017, L.P.

    ALPHABET INC.

    • 10% Owner
    		 1,924,474 2018-03-19 0

    HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

    • 10% Owner
    		 No longer subject to file 2018-03-19 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    TANG CAROLYN C. - Officer GENERAL COUNSEL

    		2022-06-21 16:23:10 -0400 2022-06-17 S 1,073 $22.29 d 23,909 direct 6.2075 6.2075 2 0.0 1

    TANG CAROLYN C. - Officer GENERAL COUNSEL

    		2022-06-21 16:23:10 -0400 2022-06-17 S 449 $21.71 d 24,982 direct 6.2075 6.2075 2 0.0 1

    ROSEN TERRY J - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-06-21 16:21:40 -0400 2022-06-17 S 3,252 $22.29 d 227,716 direct 6.2075 6.2075 2 0.0 1

    ROSEN TERRY J - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-06-21 16:21:40 -0400 2022-06-17 S 1,361 $21.71 d 230,968 direct 6.2075 6.2075 2 0.0 1

    JAEN JUAN C. - Director - Officer PRESIDENT

    		2022-06-21 16:18:07 -0400 2022-06-17 S 1,789 $22.29 d 210,037 direct 6.2075 6.2075 2 0.0 1

    JAEN JUAN C. - Director - Officer PRESIDENT

    		2022-06-21 16:18:07 -0400 2022-06-17 S 748 $21.71 d 211,826 direct 6.2075 6.2075 2 0.0 1

    JARRETT JENNIFER - Director - Officer CHIEF OPERATING OFFICER

    		2022-06-21 16:19:35 -0400 2022-06-17 S 4,663 $22.29 d 118,619 direct 6.2075 6.2075 2 0.0 1

    JARRETT JENNIFER - Director - Officer CHIEF OPERATING OFFICER

    		2022-06-21 16:19:35 -0400 2022-06-17 S 1,951 $21.71 d 123,282 direct 6.2075 6.2075 2 0.0 1

    TANG CAROLYN C. - Officer GENERAL COUNSEL

    		2022-06-21 16:23:10 -0400 2022-06-16 S 1,400 $20.72 d 25,431 direct 6.2075 6.2075 2 0.0 1

    ROSEN TERRY J - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-06-21 16:21:40 -0400 2022-06-16 S 4,241 $20.72 d 232,329 direct 6.2075 6.2075 2 0.0 1

    JAEN JUAN C. - Director - Officer PRESIDENT

    		2022-06-21 16:18:07 -0400 2022-06-16 S 2,333 $20.72 d 212,574 direct 6.2075 6.2075 2 0.0 1

    JARRETT JENNIFER - Director - Officer CHIEF OPERATING OFFICER

    		2022-06-21 16:19:35 -0400 2022-06-16 S 6,081 $20.72 d 125,233 direct 6.2075 6.2075 2 0.0 1

    RIBAS ANTONI - Director

    		2022-06-16 16:35:43 -0400 2022-06-14 A 16,800 a 16,800 direct

    KANEKO YASUNORI - Director

    		2022-06-16 16:21:33 -0400 2022-06-14 A 4,100 a 4,100 direct 6.9936 6.9936 2 0.0 1

    RIBAS ANTONI - Director

    		2022-06-16 16:35:43 -0400 2022-06-14 A 4,100 a 15,150 direct 6.9936 6.9936 2 0.0 1

    PERLMAN ANDREW J - Director

    		2022-06-16 16:34:03 -0400 2022-06-14 A 16,800 a 16,800 direct

    PERLMAN ANDREW J - Director

    		2022-06-16 16:34:03 -0400 2022-06-14 A 4,100 a 11,125 direct 6.9936 6.9936 2 0.0 1

    LAMBERT NICOLE - Director

    		2022-06-16 16:25:00 -0400 2022-06-14 A 16,800 a 16,800 direct

    LAMBERT NICOLE - Director

    		2022-06-16 16:25:00 -0400 2022-06-14 A 4,100 a 4,100 direct 6.9936 6.9936 2 0.0 1

    MACHADO PATRICK - Director

    		2022-06-16 16:26:38 -0400 2022-06-14 A 16,800 a 16,800 direct

    MACHADO PATRICK - Director

    		2022-06-16 16:26:38 -0400 2022-06-14 A 4,100 a 10,100 direct 6.9936 6.9936 2 0.0 1

    LACEY DAVID L. - Director

    		2022-06-16 16:23:36 -0400 2022-06-14 A 16,800 a 16,800 direct

    LACEY DAVID L. - Director

    		2022-06-16 16:23:36 -0400 2022-06-14 A 4,100 a 42,452 direct 6.9936 6.9936 2 0.0 1

    FALBERG KATHRYN E - Director

    		2022-06-16 16:19:54 -0400 2022-06-14 A 16,800 a 16,800 direct

    FALBERG KATHRYN E - Director

    		2022-06-16 16:19:54 -0400 2022-06-14 A 4,100 a 90,604 direct 6.9936 6.9936 2 0.0 1

    KANEKO YASUNORI - Director

    		2022-06-16 16:21:33 -0400 2022-06-14 A 16,800 a 16,800 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 22:15:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 21:45:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 21:15:04 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 20:45:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 20:15:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 19:45:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 19:15:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 18:45:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 18:15:04 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 17:45:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 17:15:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 16:45:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 16:15:03 UTC 1.32 0.25 400000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 15:45:03 UTC 1.32 0.25 350000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 15:15:03 UTC 1.32 0.25 350000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 14:45:03 UTC 1.32 0.25 350000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 14:15:03 UTC 1.32 0.25 350000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 13:45:03 UTC 1.32 0.25 350000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 13:15:03 UTC 1.32 0.25 350000
    ARCUS BIOSCIENCES INC RCUS 2022-06-24 12:45:03 UTC 1.32 0.25 350000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund RCUS -141.0 shares, $-4342.8 2022-01-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund RCUS -2502.0 shares, $-77061.6 2022-01-31 N-PORT
    RUSSELL INVESTMENT CO- Sustainable Equity Fund RCUS -1112.0 shares, $-34249.6 2022-01-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund RCUS -422.0 shares, $-13318.32 2022-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund RCUS -1200.0 shares, $-5592.0 2022-03-31 N-PORT

    Elevate your investments